Chemoinformaics analysis of (20s)-3beta-30-dihydroxylupane
Molecular Weight | 444.744 | nRot | 1 |
Heavy Atom Molecular Weight | 392.328 | nRig | 25 |
Exact Molecular Weight | 444.397 | nRing | 5 |
Solubility: LogS | -4.884 | nHRing | 0 |
Solubility: LogP | 6.553 | No. of Aliphatic Rings | 5 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
Atoms Count | 84 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 5 |
No. of Hydrogen atom | 52 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 30 | No. of Saturated Rings | 5 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 86.3772 |
nHD | 2 | BPOL | 52.1668 |
QED | 0.448 |
Synth | 4.747 |
Natural Product Likeliness | 2.96 |
NR-PPAR-gamma | 0.014 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.041 |
Pgp-sub | 0 |
HIA | 0.003 |
CACO-2 | -5.092 |
MDCK | 0.000024 |
BBB | 0.029 |
PPB | 0.943215 |
VDSS | 1.133 |
FU | 0.0158457 |
CYP1A2-inh | 0.034 |
CYP1A2-sub | 0.488 |
CYP2c19-inh | 0.071 |
CYP2c19-sub | 0.944 |
CYP2c9-inh | 0.114 |
CYP2c9-sub | 0.584 |
CYP2d6-inh | 0.027 |
CYP2d6-sub | 0.59 |
CYP3a4-inh | 0.188 |
CYP3a4-sub | 0.326 |
CL | 3.866 |
T12 | 0.147 |
hERG | 0.09 |
Ames | 0.001 |
ROA | 0.102 |
SkinSen | 0.727 |
Carcinogencity | 0.003 |
EI | 0.856 |
Respiratory | 0.87 |
NR-Aromatase | 0.027 |
Antiviral | No |
Prediction | 0.9003 |